Israel Financial Statements From 2010 to 2024

ICB Stock   605.10  14.90  2.40%   
Israel China financial statements provide useful quarterly and yearly information to potential Israel China Biotechnology investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Israel China financial statements helps investors assess Israel China's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Israel China's valuation are summarized below:
Israel China Biotechnology does not presently have any fundamental trends for analysis.
Check Israel China financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Israel China's main balance sheet or income statement drivers, such as , as well as many indicators such as . Israel financial statements analysis is a perfect complement when working with Israel China Valuation or Volatility modules.
  
This module can also supplement various Israel China Technical models . Check out the analysis of Israel China Correlation against competitors.

Israel China Biotechnology Company Operating Margin Analysis

Israel China's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Israel China Operating Margin

    
  135.33 %  
Most of Israel China's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Israel China Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Israel China Biotechnology has an Operating Margin of 135%. This is 485.78% lower than that of the Healthcare sector and significantly higher than that of the Health Care Equipment & Supplies industry. The operating margin for all Israel stocks is notably lower than that of the firm.

Israel China Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Israel China's current stock value. Our valuation model uses many indicators to compare Israel China value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Israel China competition to find correlations between indicators driving Israel China's intrinsic value. More Info.
Israel China Biotechnology is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Israel China by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Israel China's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Israel China Financial Statements

Israel China stakeholders use historical fundamental indicators, such as Israel China's revenue or net income, to determine how well the company is positioned to perform in the future. Although Israel China investors may analyze each financial statement separately, they are all interrelated. For example, changes in Israel China's assets and liabilities are reflected in the revenues and expenses on Israel China's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Israel China Biotechnology. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Israel Stock

Israel China financial ratios help investors to determine whether Israel Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Israel with respect to the benefits of owning Israel China security.